NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness.
BACKGROUND
The psychotomimetics ketamine and MK-801, non-competitive NMDA receptor (NMDAr) antagonists, induce cognitive impairment and aggravate schizophrenia symptoms. In conscious rats, they produce an abnormal behavior associated with a peculiar brain state characterized by increased synchronization in ongoing gamma (30-80 Hz) oscillations in the frontoparietal (sensorimotor) electrocorticogram (ECoG). This study investigated whether NMDAr antagonists-induced aberrant gamma oscillations are correlated with locomotion and dependent on hyperlocomotion-related sensorimotor processing. This also implied to explore the contribution of intracortical and subcortical networks in the generation of these pathophysiological ECoG gamma oscillations.


RESULTS
Quantitative locomotion data collected with a computer-assisted video tracking system in combination with ECoG revealed that ketamine and MK-801 induce highly correlated hyperlocomotion and aberrant gamma oscillations. This abnormal gamma hyperactivity was recorded over the frontal, parietal and occipital cortices. ECoG conducted under diverse consciousness states (with diverse anesthetics) revealed that NMDAr antagonists dramatically increase the power of basal gamma oscillations. Paired ECoG and intracortical local field potential recordings showed that the ECoG mainly reflects gamma oscillations recorded in underlying intracortical networks. In addition, multisite recordings revealed that NMDAr antagonists dramatically enhance the amount of ongoing gamma oscillations in multiple cortical and subcortical structures, including the prefrontal cortex, accumbens, amygdala, basalis, hippocampus, striatum and thalamus.


CONCLUSIONS
NMDAr antagonists acutely produces, in the rodent CNS, generalized aberrant gamma oscillations, which are not dependent on hyperlocomotion-related brain state or conscious sensorimotor processing. These findings suggest that NMDAr hypofunction-related generalized gamma hypersynchronies represent an aberrant diffuse network noise, a potential electrophysiological correlate of a psychotic-like state. Such generalized noise might cause dysfunction of brain operations, including the impairments in cognition and sensorimotor integration seen in schizophrenia.
Hakami
Tahir
T
Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.
Jones
Nigel C
NC
Tolmacheva
Elena A
EA
Gaudias
Julien
J
Chaumont
Joseph
J
Salzberg
Michael
M
O'Brien
Terence J
TJ
Pinault
Didier
D
D000818:Animals; D003243:Consciousness; D016291:Dizocilpine Maleate / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology*; D007649:Ketamine / Q000494:pharmacology; D008124:Locomotion; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000502:physiology*
D018691:Excitatory Amino Acid Antagonists; D016194:Receptors, N-Methyl-D-Aspartate; D007649:Ketamine; D016291:Dizocilpine Maleate
Neuron. 2006 Oct 5;52(1):139-53
17015232
J Neurosci Methods. 1996 Apr;65(2):113-36
8740589
Brain. 1999 Apr;122 ( Pt 4):593-624
10219775
Clin Neurophysiol. 2005 Dec;116(12):2719-33
16253555
Psychopharmacology (Berl). 2008 Jun;198(3):363-74
18437299
J Neurosci. 2007 Aug 29;27(35):9369-79
17728450
J Neurophysiol. 1989 Feb;61(2):311-30
2918357
Psychopharmacology (Berl). 2007 May;191(4):961-74
17219218
Vision Res. 1986;26(9):1461-80
3303669
Neuropsychopharmacology. 1999 Feb;20(2):106-18
9885791
Eur J Neurosci. 2000 Apr;12(4):1420-30
10762370
Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8996-9000
1924362
J Neurosci. 2007 Oct 24;27(43):11496-500
17959792
Int J Psychophysiol. 2007 Apr;64(1):39-45
16962192
Int Rev Neurobiol. 2007;78:69-108
17349858
Biol Psychiatry. 2008 Feb 15;63(4):349-52
17643398
Neuropsychopharmacology. 2007 Mar;32(3):719-27
16525415
Nature. 1995 Feb 16;373(6515):612-5
7854418
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17288-93
15546988
Nat Rev Neurosci. 2007 Jan;8(1):45-56
17180162
Neuron. 2003 Jan 23;37(2):311-22
12546825
J Pharmacol Exp Ther. 1976 Mar;196(3):545-55
1263110
Nature. 1998 Jul 9;394(6689):186-9
9671302
Conscious Cogn. 2009 Mar;18(1):266-76
18602838
Neuron. 2004 Sep 2;43(5):729-43
15339653
BMJ. 1993 Mar 6;306(6878):601-2
8461808
Brain Res Bull. 2006 Apr 14;69(3):338-45
16564431
Glia. 2008 Nov 15;56(15):1648-63
18618659
J Neurosci Methods. 1980 Dec;3(2):129-49
6110810
Neuroscience. 1993 Sep;56(1):1-9
8232908
Biol Psychiatry. 1998 Jun 1;43(11):811-6
9611670
Schizophr Bull. 2008 Sep;34(5):944-61
18586694
J Neurosci. 2002 Sep 15;22(18):8158-69
12223570
World Psychiatry. 2002 Jun;1(2):66-71
16946855
Biol Psychiatry. 2004 Jun 15;55(12):1146-53
15184033
Synapse. 2005 Dec 15;58(4):275-7
16206157
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11748-51
7972135
Neuron. 2003 Dec 4;40(5):881-4
14659087
J Cogn Neurosci. 2009 May;21(5):875-89
18702577
Hum Psychopharmacol. 2008 Oct;23(7):549-54
18546441
Biol Psychiatry. 2006 May 15;59(10):929-39
16427028
Am J Psychiatry. 2008 Dec;165(12):1585-93
18923067
Brain Res. 2000 Feb 14;855(2):217-24
10677593
Lancet. 1998 Aug 22;352(9128):620-1
9746027
J Neurosci. 2008 Apr 23;28(17):4512-20
18434529
Schizophr Res. 2002 Oct 1;57(2-3):281-91
12223260
Neuron. 2006 Oct 5;52(1):155-68
17015233
J Neurosci. 1997 Apr 15;17(8):2921-7
9092613
Neuroscience. 1992 Nov;51(2):245-58
1465191
Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):897-901
1992481
Conscious Cogn. 2003 Sep;12(3):413-51
12941286
Biol Psychiatry. 2008 Apr 15;63(8):730-5
18022604
Nature. 1989 Mar 23;338(6213):334-7
2922061
Neuroscience. 2001;105(1):181-201
11483311
J Psychiatr Res. 1999 Nov-Dec;33(6):523-33
10628529
Am J Psychiatry. 2004 Apr;161(4):751-5
15056526
Arch Gen Psychiatry. 2004 Jul;61(7):649-57
15237077
Schizophr Bull. 2008 Sep;34(5):962-73
18544550
Science. 1936 Mar 13;83(2150):259-60
17757098
Biol Psychiatry. 2006 Dec 1;60(11):1231-40
16893524
Mol Psychiatry. 2002;7(8):837-44
12232776
Psychiatry Res. 2007 Aug 30;152(2-3):155-64
17512059
Arch Gen Psychiatry. 1994 Mar;51(3):199-214
8122957
Neuroreport. 2005 Dec 19;16(18):2021-4
16317346
Biol Psychiatry. 2006 Apr 15;59(8):721-9
16427029
Biol Psychiatry. 2006 Dec 1;60(11):1206-14
16650831
Cogn Neuropsychiatry. 2003 Feb;8(1):57-71
16571550
Psychopharmacology (Berl). 2000 Oct;152(3):283-8
11105938
Neuroscience. 2008 Jun 23;154(2):454-60
18472348
Neuroscience. 1992 Nov;51(1):7-10
1465188
Eur J Neurosci. 1996 Jan;8(1):169-82
8713461